📅Offer Date: 21 May 2026 – 25 May 2026
Data sourced from BSE & NSE · Last updated
Bio Medica Laboratories Limited IPO was subscribed 2.31x in total when bidding closed on 25 May 2026, with 15.94x in the QIB category, 1.41x in NII, 2.92x in retail. The issue ran from 21 May 2026 to 25 May 2026 at a price band of ₹132.00–₹139.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (2.92x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 36,000 | 5,73,840 | 15.94x |
| NIIs | 17,55,000 | 24,74,550 | 1.41x |
| SNIIs (<10L) | 5,85,000 | 12,81,150 | 2.19x |
| BNIIs (>10L) | 11,70,000 | 11,93,400 | 1.02x |
| Retail | 17,92,000 | 52,32,640 | 2.92x |
| Total | 35,83,000 | 82,76,730 | 2.31x |
| QIB / NII | 36,000 | 0 | 0.00x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 0.50 | 7.98 | 15.94x |
| NIIs | 24.39 | 34.40 | 1.41x |
| Retail | 24.91 | 72.73 | 2.92x |
| QIB / NII | 0.50 | — | 0.00x |
| Total | 50.30 | 115.11 | 2.31x |
Values derived from share count × issue price (₹139.00)
Because Bio Medica Laboratories Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
NSE SME listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.